Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteins.
about
PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia CellsHistone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemiaPhase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia.The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis, down-regulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cellsE-cadherin gene re-expression in chronic lymphocytic leukemia cells by HDAC inhibitors.Identifying an uptake mechanism for the antiepileptic and bipolar disorder treatment valproic acid using the simple biomedical model Dictyostelium.Targeting the epigenome: effects of epigenetic treatment strategies on genomic stability in healthy human cellsThe correlation between telomerase activity and Bax/Bcl-2 ratio in valproic acid-treated MCF-7 breast cancer cell lineRepurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma.Using an exon microarray to identify a global profile of gene expression and alternative splicing in K562 cells exposed to sodium valproate.Valproic acid overcomes hypoxia-induced resistance to apoptosis.Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS)Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin BCharacterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significanceEpigenetic therapy of lymphoma using histone deacetylase inhibitors.Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part II: targeting cell cycle events, caspases, NF-κB and the proteasome.Promising therapies for the treatment of chronic lymphocytic leukemia.Valproic acid inhibits proliferation of EB virus-infected natural killer cells.Valproic acid induced differentiation and potentiated efficacy of taxol and nanotaxol for controlling growth of human glioblastoma LN18 and T98G cells.Histone deacetylase inhibitor valproic acid sensitizes B16F10 melanoma cells to cucurbitacin B treatment.Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation.Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis.Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells.Evaluation of attenuative effect of tert-butylhydroquinone against diazinon-induced oxidative stress on hematological indices in male Wistar rats.
P2860
Q21328686-21F6B04C-37B6-44C9-B322-E51962D9BFBAQ24633394-1C84B7FB-D1A6-4FB9-A6FD-D428C61DC42DQ33386193-03522011-660E-41E8-A287-E4B8146BE90FQ33952785-CFCE07E0-0B8E-4333-8874-FF85FD08C376Q34595859-E0004CEF-8E8C-42C7-A959-74A44E267F2BQ35041292-F6361FBA-36A3-48DC-9B79-868B7251D1EAQ36001852-36D4AF08-0623-46A9-86DF-B35D5ACD15C5Q36017178-A9980B12-7067-4DB7-AFB5-86BA5331A1CDQ36380213-A0EAD64E-AACA-4118-9A07-2C91C1102FBDQ36642277-B122F3EE-09D7-4C69-9294-6BD42112428BQ36642574-8CCA654E-061A-4776-8790-B7285D8BC22BQ37219274-3E7959B1-6F94-4C3A-BE7F-E752F86B6FE2Q37275725-5C27D75C-1998-4917-899D-387932469862Q37480308-4BC9B1C3-0257-47AD-B4F8-28B015CC8884Q37763784-C9204AF6-06D4-44CF-AAEC-B04AAB452AF8Q38088360-8E47D3E9-5659-4A52-B108-F1B8E2E1CAEAQ38366441-33666858-39E9-44DC-8A10-9262638AF01EQ39337509-7D2EDAB4-E5D0-40B0-A295-A5103528F4BEQ39501439-7543F68D-0103-45CD-8FAD-10B58BD804C0Q39532988-07E58038-21FF-4392-B678-5BA0B5A5449BQ42739964-7E6F6BFB-035A-42E5-9829-A5797244ADDBQ43285192-1641E8A9-59EA-4AC4-A4C7-502D9FD57A52Q44638649-1D8159D0-FD3C-4175-A073-DD85ACA96A5AQ55078623-CAD1BDD9-07D5-4989-866A-8CE7F5A328FC
P2860
Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteins.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Valproic acid sensitizes chron ...... o- and antiapoptotic proteins.
@ast
Valproic acid sensitizes chron ...... o- and antiapoptotic proteins.
@en
type
label
Valproic acid sensitizes chron ...... o- and antiapoptotic proteins.
@ast
Valproic acid sensitizes chron ...... o- and antiapoptotic proteins.
@en
prefLabel
Valproic acid sensitizes chron ...... o- and antiapoptotic proteins.
@ast
Valproic acid sensitizes chron ...... o- and antiapoptotic proteins.
@en
P2860
P1433
P1476
Valproic acid sensitizes chron ...... o- and antiapoptotic proteins.
@en
P2093
Imke Bokelmann
P2860
P2888
P356
10.2119/2007-00084.BOKELMANN
P407
P577
2008-01-01T00:00:00Z
P6179
1068965031